Valuation: Medicure Inc.

Market Cap 10.85M 7.7M 6.77M 6.29M 5.79M 746M 11.05M 75.25M 29.35M 364M 28.91M 28.29M 1.26B P/E 2024
-8.8x
P/E 2025 -1.68x
Enterprise Value 7.91M 5.61M 4.94M 4.59M 4.22M 544M 8.05M 54.84M 21.39M 265M 21.07M 20.62M 920M EV / Sales 2024
0.13x
EV / Sales 2025 0.31x
Free-Float
72.7%
Yield 2024 *
-
Yield 2025 -
1 day-7.96%
1 week-2.80%
Current month-19.38%
1 month-16.80%
3 months-22.96%
6 months-15.45%
Current year-8.77%
1 week 1.04
Extreme 1.04
1.13
1 month 1.04
Extreme 1.04
1.29
Current year 0.85
Extreme 0.85
1.35
1 year 0.85
Extreme 0.85
1.43
3 years 0.63
Extreme 0.63
1.8
5 years 0.63
Extreme 0.63
1.8
10 years 0
Extreme 0
10.67
Manager TitleAgeSince
Chief Executive Officer 79 14/09/1997
Director of Finance/CFO - 31/05/2022
Chief Tech/Sci/R&D Officer - 30/06/2019
Director TitleAgeSince
Chairman 79 14/09/1997
Director/Board Member 92 27/02/2000
Director/Board Member 56 21/01/2013
Date Insider Type Main position Quantity % Market Cap.
22/06/26 Buy

Chief Executive Officer

1,000 0.0096%
22/06/26 Buy

Chief Executive Officer

200 0.0019%
22/06/26 Buy

Chief Executive Officer

2,500 0.0240%
Change 5-day change 1-year change 3-year change Capi.($)
-7.96%-2.80%-16.80%-16.80% 7.7M
+1.23%+0.35%+51.62%+87.98% 55.92B
+5.09%+6.24%+63.15%+62.06% 56.67B
+0.25%+0.55%-19.67%-15.22% 23.28B
+0.72%-0.05%+3.84%+409.54% 23.28B
-1.43%+4.65%+29.65%-4.56% 20.54B
-0.37%+0.71%+31.36%-31.61% 17.78B
-1.05%+5.88%+32.80%+545.36% 15.9B
-2.54%-8.73%+164.11%+289.45% 14.64B
+1.22%-0.05%+22.58%+182.63% 13.99B
Average -0.50%+1.14%+36.26%+150.88% 24.2B
Weighted average by Cap. +1.26%+3.18%+43.40%+133.98%

Financials

2024 2025
Net sales 21.91M 15.55M 13.67M 12.7M 11.68M 1.51B 22.3M 152M 59.24M 734M 58.36M 57.1M 2.55B 28.86M 20.48M 18.01M 16.73M 15.39M 1.98B 29.37M 200M 78.03M 967M 76.87M 75.21M 3.36B
Net income -1.04M -737K -648K -602K -554K -71.4M -1.06M -7.2M -2.81M -34.83M -2.77M -2.71M -121M -7.1M -5.04M -4.43M -4.11M -3.78M -488M -7.22M -49.2M -19.19M -238M -18.91M -18.5M -825M
Net Debt -6.32M -4.48M -3.94M -3.66M -3.37M -434M -6.43M -43.8M -17.08M -212M -16.83M -16.46M -735M -2.94M -2.09M -1.84M -1.71M -1.57M -202M -3M -20.41M -7.96M -98.68M -7.84M -7.67M -342M
Logo Medicure Inc.
Medicure Inc. is a pharmaceutical company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market. Its primary focus is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through its United States subsidiary, Medicure Pharma Inc. It operates Marley Drug Inc. (Marley Drug), a pharmacy subsidiary servicing all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving access to medications for all Americans, together with customer service and free home delivery. It operates Gateway Medical Pharmacy, located in Portland, Oregon in a medical office building near transportation lines and multiple healthcare clinics and centers. It develops pyridoxal 5'-phosphate analogues (P5P Analogues), the processes for their preparation, and compositions containing P5P Analogues.
Employees
38
Date Price Change Volume
23/07/26 CA$1.040 -7.96% 100
22/07/26 CA$1.130 +5.61% 1,100